JOINTOWN PHARMACEUTICAL GROUP C

JOINTOWN PHARMACEUTICAL GROUP C — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
+Revenue	151.8B	150.1B	140.4B	122.4B	110.9B	99.5B	87.1B	73.9B	61.6B	49.6B	41.1B	33.4B	29.5B	24.8B	21.2B	19.0B	16.3B	13.0B
Revenue Growth %	1.1%	6.9%	14.7%	10.4%	11.4%	14.2%	17.8%	20.1%	24.1%	20.7%	22.8%	13.3%	18.8%	17.2%	11.7%	16.4%	24.8%	--
Total Revenue	151.8B	150.1B	140.4B	122.4B	110.9B	99.5B	87.1B	73.9B	61.6B	49.6B	41.1B	33.4B	29.5B	24.8B	21.2B	19.0B	16.3B	13.0B
Cost Of Revenue	140.0B	138.0B	129.5B	112.6B	100.9B	90.8B	79.6B	67.7B	56.7B	45.8B	38.2B	31.2B	27.6B	23.3B	19.8B	17.8B	15.4B	12.4B
+Gross Profit	11.8B	12.1B	10.9B	9.8B	9.9B	8.7B	7.5B	6.2B	4.8B	3.8B	2.9B	2.2B	1.9B	1.5B	1.4B	1.2B	919.0M	659.0M
Gross Margin %	7.8%	8.1%	7.8%	8.0%	9.0%	8.7%	8.6%	8.4%	7.8%	7.6%	7.1%	6.7%	6.4%	6.1%	6.6%	6.1%	5.6%	5.1%
Total Operating Cost	149.2B	147.4B	138.2B	120.5B	108.2B	97.5B	85.5B	72.6B	60.5B	48.8B	40.5B	33.0B	29.1B	24.5B	20.7B	18.6B	16.0B	12.9B
Selling Expenses	4.4B	4.4B	4.1B	3.7B	3.5B	3.1B	2.8B	2.3B	1.6B	1.2B	1.1B	789.0M	679.0M	546.0M	463.0M	379.0M	317.0M	225.0M
Admin Expenses	2.9B	2.8B	2.5B	2.5B	2.2B	2.0B	1.8B	1.6B	1.3B	1.1B	771.0M	557.0M	465.0M	388.0M	324.0M	311.0M	248.0M	171.0M
Rd Expenses	147.0M	197.0M	178.0M	195.0M	127.0M	74.1M	76.2M	73.1M	--	--	--	--	--	--	--	--	--	--
Finance Expenses	1.2B	1.2B	1.1B	1.1B	985.0M	1.2B	867.0M	703.0M	662.0M	509.0M	394.0M	361.0M	286.0M	174.0M	123.0M	75.5M	78.3M	53.0M
+Operating Income	3.6B	3.0B	2.9B	3.6B	4.4B	2.3B	1.8B	1.9B	1.0B	860.0M	642.0M	513.0M	493.0M	350.0M	445.0M	358.0M	255.0M	197.0M
Operating Margin %	2.4%	2.0%	2.0%	2.9%	3.9%	2.3%	2.1%	2.6%	1.7%	1.7%	1.6%	1.5%	1.7%	1.4%	2.1%	1.9%	1.6%	1.5%
Non Operating Income	64.4M	63.9M	54.0M	39.2M	74.2M	47.4M	32.6M	9.5M	98.1M	114.0M	126.0M	99.1M	66.8M	146.0M	40.3M	24.5M	20.5M	9.9M
Non Operating Expenses	62.0M	95.8M	69.0M	269.0M	92.6M	31.4M	31.8M	26.5M	38.4M	18.3M	14.2M	5.6M	7.1M	6.8M	7.5M	5.1M	11.3M	4.5M
Investment Income	1.3B	32.4M	298.0M	171.0M	140.0M	140.0M	55.1M	39.9M	8.7M	47.5M	41.3M	57.7M	91.3M	5.7M	-2.1M	2.3M	5.2M	2.6M
Fair Value Change Income	-21.4M	-58.8M	60.4M	1.3B	1.1B	-14.0M	4.9M	-10.9M	7.0M	--	312,600	1.6M	-2.0M	--	--	--	--	--
Asset Disposal Income	-424.0M	6.9M	48.2M	6.7M	258.0M	7.2M	6.6M	488.0M	-3.2M	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	85.4M	70.8M	61.0M	52.0M	32.8M	12.6M	67.4M	93.9M	92.9M	52.6M	29.3M	19.0M	9.5M	11.4M	4.6M	3.7M	5.4M	2.9M
Other Income	217.0M	289.0M	253.0M	262.0M	214.0M	203.0M	97.5M	72.3M	--	--	--	--	--	--	--	--	--	--
Income Before Tax	3.6B	3.0B	2.8B	3.4B	4.3B	2.3B	1.8B	1.9B	1.1B	956.0M	753.0M	607.0M	552.0M	490.0M	478.0M	378.0M	264.0M	202.0M
Income Tax	851.0M	701.0M	553.0M	755.0M	949.0M	536.0M	449.0M	452.0M	201.0M	252.0M	185.0M	136.0M	140.0M	114.0M	112.0M	73.8M	61.2M	43.0M
+Net Income	2.8B	2.3B	2.3B	2.6B	3.4B	1.8B	1.4B	1.5B	904.0M	704.0M	568.0M	471.0M	413.0M	376.0M	366.0M	304.0M	203.0M	159.0M
Net Margin %	1.8%	1.5%	1.6%	2.1%	3.1%	1.8%	1.6%	2.0%	1.5%	1.4%	1.4%	1.4%	1.4%	1.5%	1.7%	1.6%	1.2%	1.2%
Net Income Attributable	2.5B	2.2B	2.1B	2.4B	3.1B	1.7B	1.3B	1.4B	877.0M	695.0M	561.0M	478.0M	413.0M	374.0M	360.0M	298.0M	203.0M	160.0M
Minority Interest	279.0M	116.0M	201.0M	160.0M	310.0M	54.9M	40.9M	27.4M	27.6M	9.3M	7.6M	-7.0M	-117,400	1.4M	6.8M	5.9M	24,300	-354,300
Eps Basic	0.50	0.43	0.51	1.27	1.60	0.85	0.73	0.87	0.54	0.43	0.36	0.34	0.29	0.26	0.27	0.25	0.17	0.34
Eps Diluted	0.50	0.43	0.51	1.27	1.55	0.84	0.72	0.85	0.54	0.43	0.36	0.34	0.29	0.26	0.27	0.25	0.17	0.34

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash And Equivalents	17.4B	16.9B	17.2B	14.7B	14.8B	12.2B	12.7B	8.5B	5.2B	6.1B	3.6B	3.2B	2.4B	2.1B	1.2B	1.6B	1.4B	1.1B
Trading Financial Assets	972.0M	90.0M	320.0M	3.6B	15.3M	--	967,400	--	7.0M	--	--	4.0M	8.0M	--	--	--	--	--
Accounts Receivable	29.5B	24.7B	27.6B	26.4B	25.1B	22.9B	20.7B	14.1B	9.1B	7.8B	5.1B	2.8B	1.7B	927.0M	556.0M	360.0M	220.0M	249.0M
Notes Receivable	243.0M	170.0M	288.0M	278.0M	151.0M	184.0M	1.4B	1.7B	2.2B	632.0M	1.0B	1.1B	1.1B	826.0M	399.0M	148.0M	68.1M	42.0M
Notes And Accounts Receivable	29.7B	24.9B	27.9B	26.7B	25.2B	23.1B	22.1B	15.8B	11.3B	8.4B	6.1B	3.9B	2.8B	1.8B	955.0M	507.0M	288.0M	291.0M
Prepayments	5.4B	4.1B	5.9B	4.1B	3.7B	3.2B	3.8B	2.6B	2.2B	2.1B	1.8B	1.8B	1.5B	1.3B	696.0M	812.0M	570.0M	370.0M
Inventory	22.9B	20.1B	17.2B	15.5B	14.8B	14.1B	13.9B	12.2B	10.2B	8.1B	6.3B	4.9B	4.1B	3.8B	3.1B	2.6B	2.1B	1.6B
Total Current Assets	84.2B	75.6B	75.7B	71.2B	66.2B	58.9B	57.1B	43.5B	32.2B	27.2B	19.9B	15.1B	11.9B	9.8B	6.5B	5.8B	4.6B	3.7B
Long Term Equity Investment	2.3B	1.9B	1.7B	1.5B	1.8B	1.7B	1.5B	853.0M	539.0M	504.0M	174.0M	173.0M	221.0M	83.4M	71.7M	52.8M	55.7M	29.0M
Fixed Assets	--	8.1B	7.5B	6.7B	5.7B	5.4B	5.2B	4.4B	3.6B	2.8B	2.4B	1.8B	1.5B	1.2B	878.0M	838.0M	632.0M	397.0M
Fixed Assets Total	8.2B	8.1B	7.5B	6.7B	5.7B	5.4B	5.2B	4.4B	3.6B	2.8B	2.4B	1.8B	1.5B	1.2B	878.0M	838.0M	632.0M	397.0M
Construction In Progress	--	635.0M	865.0M	1.5B	1.7B	1.1B	844.0M	905.0M	840.0M	756.0M	563.0M	550.0M	429.0M	339.0M	309.0M	119.0M	123.0M	151.0M
Construction In Progress Total	384.0M	635.0M	865.0M	1.5B	1.7B	1.1B	844.0M	905.0M	840.0M	756.0M	563.0M	550.0M	429.0M	339.0M	311.0M	120.0M	123.0M	151.0M
Intangible Assets	2.1B	1.9B	1.9B	2.2B	2.3B	2.2B	1.3B	1.2B	1.0B	884.0M	739.0M	631.0M	589.0M	379.0M	359.0M	331.0M	252.0M	167.0M
Long Term Deferred Expenses	135.0M	130.0M	122.0M	119.0M	109.0M	94.1M	89.9M	61.8M	51.0M	52.0M	32.4M	21.2M	37.1M	15.4M	5.7M	1.3M	585,400	5.1M
Total Non Current Assets	18.2B	17.2B	16.7B	14.8B	14.7B	12.2B	9.6B	8.6B	6.6B	5.4B	4.3B	3.4B	2.9B	2.1B	1.7B	1.4B	1.1B	750.0M
Total Assets	102.4B	92.8B	92.3B	85.9B	80.8B	71.1B	66.7B	52.0B	38.7B	32.6B	24.1B	18.6B	14.8B	11.8B	8.1B	7.2B	5.7B	4.4B
Short Term Borrowings	9.9B	10.1B	11.5B	12.6B	14.3B	11.7B	10.3B	7.0B	3.9B	5.8B	3.8B	4.2B	2.6B	2.1B	787.0M	1.5B	653.0M	682.0M
Accounts Payable	17.2B	16.2B	14.5B	12.8B	13.1B	12.3B	10.7B	10.0B	7.5B	6.3B	4.6B	3.2B	2.2B	1.8B	982.0M	966.0M	949.0M	940.0M
Advance Receipts	--	--	--	--	--	715.0M	790.0M	432.0M	293.0M	256.0M	226.0M	127.0M	97.2M	75.8M	75.5M	60.6M	36.8M	39.0M
Contract Liabilities	1.7B	1.7B	2.5B	950.0M	930.0M	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	66.4B	60.1B	59.7B	55.4B	51.3B	45.9B	44.3B	30.7B	25.3B	21.0B	14.6B	11.6B	8.3B	7.2B	3.7B	5.0B	4.0B	3.1B
Long Term Borrowings	1.0B	2.3B	3.0B	2.4B	1.7B	1.3B	242.0M	128.0M	6.5M	--	--	20.0M	50.0M	354.0M	429.0M	489.0M	265.0M	80.0M
Total Non Current Liabilities	2.4B	3.2B	3.9B	3.5B	3.9B	3.2B	2.0B	1.8B	1.5B	1.7B	1.7B	1.7B	1.7B	385.0M	455.0M	499.0M	268.0M	82.2M
Total Liabilities	68.8B	63.3B	63.6B	58.9B	55.2B	49.2B	46.3B	32.5B	26.7B	22.7B	16.3B	13.3B	10.0B	7.5B	4.1B	5.5B	4.2B	3.1B
Paid In Capital	5.0B	3.9B	1.9B	1.9B	1.9B	1.9B	1.9B	1.9B	1.6B	1.6B	1.6B	1.4B	1.4B	1.4B	1.4B	1.3B	1.2B	783.0M
Capital Reserve	5.2B	6.4B	8.2B	8.1B	8.1B	8.1B	8.0B	7.9B	4.0B	4.0B	3.9B	1.8B	1.8B	1.8B	1.8B	18.9M	16.1M	19.3M
Surplus Reserve	1.5B	1.4B	1.1B	976.0M	806.0M	573.0M	469.0M	378.0M	288.0M	235.0M	191.0M	153.0M	120.0M	91.1M	59.1M	30.7M	19.8M	210,700
Retained Earnings	14.1B	12.7B	11.9B	10.6B	9.3B	6.6B	5.3B	4.5B	3.2B	2.7B	2.0B	1.7B	1.2B	836.0M	636.0M	311.0M	235.0M	453.0M
Minority Equity	6.3B	5.5B	4.0B	3.7B	3.8B	3.2B	1.9B	1.2B	732.0M	491.0M	287.0M	240.0M	249.0M	193.0M	121.0M	41.5M	35.9M	25.3M
Equity Attributable	27.2B	24.0B	24.6B	23.4B	21.8B	18.8B	18.5B	18.3B	11.3B	9.4B	7.5B	5.1B	4.6B	4.1B	3.9B	1.6B	1.4B	1.3B
Total Equity	33.6B	29.5B	28.7B	27.1B	25.6B	22.0B	20.4B	19.5B	12.0B	9.8B	7.8B	5.3B	4.8B	4.3B	4.0B	1.7B	1.5B	1.3B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash From Sales	154.4B	151.5B	140.2B	119.4B	109.9B	109.4B	94.7B	82.0B	67.1B	57.0B	46.6B	38.8B	34.7B	28.3B	24.2B	20.8B	16.4B	14.8B
Tax Refunds Received	7.0M	13.9M	27.5M	82.7M	121.0M	16.2M	7.9M	3.5M	4.5M	4.0M	3.3M	2.5M	1.1M	495,200	9.1M	75,900	526,300	2.7M
Total Operating Cash Inflow	157.9B	154.8B	143.6B	122.7B	112.7B	112.8B	97.8B	85.0B	69.0B	58.3B	47.5B	39.5B	35.1B	28.8B	24.4B	21.1B	16.6B	15.0B
Cash Paid For Goods	141.2B	136.6B	126.5B	107.1B	99.3B	100.7B	88.9B	79.3B	63.2B	53.8B	44.4B	37.2B	33.7B	27.4B	24.2B	20.7B	15.4B	14.4B
Cash Paid To Employees	4.4B	4.3B	3.9B	3.6B	3.1B	2.8B	2.6B	2.2B	1.7B	1.3B	1.0B	741.0M	631.0M	526.0M	431.0M	347.0M	244.0M	139.0M
Taxes Paid	2.9B	3.0B	2.6B	2.4B	2.0B	1.8B	1.6B	1.3B	1.0B	820.0M	662.0M	486.0M	451.0M	389.0M	283.0M	268.0M	187.0M	172.0M
Total Operating Cash Outflow	154.8B	150.0B	139.6B	119.2B	109.2B	110.0B	96.6B	86.0B	68.6B	57.8B	47.7B	39.3B	35.5B	29.1B	25.4B	21.6B	16.1B	14.9B
Operating Cash Flow	3.1B	4.7B	4.0B	3.5B	3.4B	2.8B	1.2B	-1.0B	431.0M	436.0M	-172.0M	138.0M	-369.0M	-344.0M	-1.0B	-522.0M	495.0M	66.0M
Total Investing Cash Inflow	4.1B	1.1B	7.4B	2.8B	4.9B	1.2B	6.4B	3.2B	918.0M	230.0M	149.0M	201.0M	214.0M	117.0M	23.1M	37.7M	93.9M	14.2M
Total Investing Cash Outflow	5.7B	2.5B	5.9B	5.3B	6.2B	2.5B	7.9B	5.2B	2.4B	1.8B	1.2B	695.0M	922.0M	618.0M	425.0M	324.0M	365.0M	289.0M
Investing Cash Flow	-1.6B	-1.4B	1.5B	-2.5B	-1.3B	-1.2B	-1.5B	-2.0B	-1.5B	-1.5B	-1.0B	-494.0M	-708.0M	-501.0M	-402.0M	-287.0M	-271.0M	-275.0M
Cash From Borrowings	17.0B	17.8B	19.7B	18.5B	22.4B	23.9B	28.4B	13.4B	8.6B	9.5B	6.1B	5.9B	4.4B	3.2B	2.1B	2.2B	884.0M	831.0M
Dividends And Interest Paid	1.8B	1.7B	1.4B	1.9B	813.0M	1.2B	983.0M	728.0M	728.0M	467.0M	531.0M	365.0M	271.0M	332.0M	124.0M	282.0M	64.6M	49.2M
Debt Repayments	18.6B	17.8B	23.2B	20.2B	22.9B	26.5B	23.6B	18.1B	15.4B	8.5B	7.5B	5.2B	5.2B	1.9B	2.9B	971.0M	728.0M	605.0M
Total Financing Cash Inflow	22.8B	23.8B	23.5B	22.1B	26.1B	26.4B	29.1B	25.6B	16.3B	12.6B	9.7B	6.7B	6.8B	4.1B	4.5B	2.3B	884.0M	1.3B
Total Financing Cash Outflow	25.3B	26.1B	28.4B	24.2B	26.2B	29.2B	26.8B	19.5B	16.8B	9.8B	8.6B	5.6B	5.5B	2.5B	3.0B	1.4B	1.2B	657.0M
Financing Cash Flow	-2.5B	-2.2B	-4.9B	-2.0B	-184.0M	-2.8B	2.3B	6.1B	-416.0M	2.8B	1.1B	1.1B	1.3B	1.6B	1.5B	877.0M	-339.0M	669.0M
Net Change In Cash	-1.0B	1.1B	583.0M	-1.1B	2.0B	-1.3B	2.0B	3.1B	-1.5B	1.7B	-119.0M	778.0M	186.0M	758.0M	80.0M	68.6M	-116.0M	460.0M
Ending Cash Balance	7.8B	8.8B	7.7B	7.1B	8.2B	6.2B	7.5B	5.6B	2.5B	4.0B	2.3B	2.4B	1.6B	1.5B	696.0M	606.0M	537.0M	653.0M
Capex	975.0M	1.0B	1.2B	1.4B	1.5B	1.2B	1.8B	1.1B	1.1B	1.0B	946.0M	614.0M	623.0M	486.0M	383.0M	306.0M	315.0M	293.0M